Long-term effects of addition of mineralocorticoid receptor antagonist to angiotensin II receptor blocker in patients with diabetic nephropathy: a randomized clinical trial

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study

(2012) S. E. Nielsen et al.   DIABETIC MEDICINE

Standards of Medical Care in Diabetes--2012

(2011)   DIABETES CARE

Diagnosis and Classification of Diabetes Mellitus

(2011)   DIABETES CARE

Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease

(2011) Jean-Philippe Bertocchio et al.   KIDNEY INTERNATIONAL

Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in Iran

(2011) Mehdi Javanbakht et al.   PLoS One

Aldosterone: Role in Edematous Disorders, Hypertension, Chronic Renal Failure, and Metabolic Syndrome

(2010) R. W. Schrier et al.   Clinical Journal of the American Society of Nephrology

Mineralocorticoid Receptor Antagonists and the Metabolic Syndrome

(2010) Amir Tirosh et al.   CURRENT HYPERTENSION REPORTS

Predictors of Hyperkalemia Risk following Hypertension Control with Aldosterone Blockade

(2009) Nitin Khosla et al.   AMERICAN JOURNAL OF NEPHROLOGY

Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes

(2009) T. Ninomiya et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy

(2009) U. F. Mehdi et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

New aspects of rapid aldosterone signaling

(2009) C. Grossmann et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Change in Proteinuria After Adding Aldosterone Blockers to ACE Inhibitors or Angiotensin Receptor Blockers in CKD: A Systematic Review

(2008) Andrew S. Bomback et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Aldosterone and glomerular podocyte injury

(2008) Miki Nagase et al.   Clinical and Experimental Nephrology

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

(2008) Johannes FE Mann et al.   LANCET